# Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease

> **NCT01397539** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 53 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** BIIB037
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01397539
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2015-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01397539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01397539, "Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease". Retrieved via MORVS 2026-10-29 from https://api.morvs.ai/clinical/NCT01397539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*